🎉 M&A multiples are live!
Check it out!

Initiator Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Initiator Pharma and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

Initiator Pharma Overview

About Initiator Pharma

Initiator Pharma AS is a research and development company engaged in the pharmaceutical development of drugs to be used for erectile dysfunction, depression, and pain. It Research is focused in the area of monoamine reuptake inhibitors.


Founded

2016

HQ

Sweden
Employees

3

Financials

LTM Revenue $5.5M

LTM EBITDA $2.6M

EV

$33.0M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Initiator Pharma Financials

Initiator Pharma has a last 12-month revenue of $5.5M and a last 12-month EBITDA of $2.6M.

In the most recent fiscal year, Initiator Pharma achieved revenue of n/a and an EBITDA of -$1.4M.

Initiator Pharma expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Initiator Pharma valuation multiples based on analyst estimates

Initiator Pharma P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit -$3.8M -$2.3M XXX XXX XXX
Gross Margin NaN% -Infinity% XXX XXX XXX
EBITDA -$2.7M -$1.4M XXX XXX XXX
EBITDA Margin NaN% -Infinity% XXX XXX XXX
Net Profit -$3.8M -$2.3M XXX XXX XXX
Net Margin NaN% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Initiator Pharma Stock Performance

As of April 15, 2025, Initiator Pharma's stock price is SEK 6 (or $1).

Initiator Pharma has current market cap of SEK 353M (or $35.0M), and EV of SEK 333M (or $33.0M).

See Initiator Pharma trading valuation data

Initiator Pharma Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$33.0M $35.0M XXX XXX XXX XXX $0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Initiator Pharma Valuation Multiples

As of April 15, 2025, Initiator Pharma has market cap of $35.0M and EV of $33.0M.

Initiator Pharma's trades at 8.8x LTM EV/Revenue multiple, and 18.1x LTM EBITDA.

Analysts estimate Initiator Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Initiator Pharma and 10K+ public comps

Initiator Pharma Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $33.0M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -22.9x XXX XXX XXX
P/E -27.3x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -27.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Initiator Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Initiator Pharma Valuation Multiples

Initiator Pharma's NTM/LTM revenue growth is 148%

Initiator Pharma's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Initiator Pharma's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Initiator Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Initiator Pharma and other 10K+ public comps

Initiator Pharma Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -46% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Initiator Pharma Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Initiator Pharma M&A and Investment Activity

Initiator Pharma acquired  XXX companies to date.

Last acquisition by Initiator Pharma was  XXXXXXXX, XXXXX XXXXX XXXXXX . Initiator Pharma acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Initiator Pharma

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Initiator Pharma

When was Initiator Pharma founded? Initiator Pharma was founded in 2016.
Where is Initiator Pharma headquartered? Initiator Pharma is headquartered in Sweden.
How many employees does Initiator Pharma have? As of today, Initiator Pharma has 3 employees.
Is Initiator Pharma publicy listed? Yes, Initiator Pharma is a public company listed on STO.
What is the stock symbol of Initiator Pharma? Initiator Pharma trades under INIT ticker.
When did Initiator Pharma go public? Initiator Pharma went public in 2017.
Who are competitors of Initiator Pharma? Similar companies to Initiator Pharma include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Initiator Pharma? Initiator Pharma's current market cap is $35.0M
What is the current revenue of Initiator Pharma? Initiator Pharma's last 12-month revenue is $5.5M.
What is the current EBITDA of Initiator Pharma? Initiator Pharma's last 12-month EBITDA is $2.6M.
What is the current EV/Revenue multiple of Initiator Pharma? Current revenue multiple of Initiator Pharma is 8.8x.
What is the current EV/EBITDA multiple of Initiator Pharma? Current EBITDA multiple of Initiator Pharma is 18.1x.
Is Initiator Pharma profitable? Yes, Initiator Pharma is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.